Ingalls & Snyder LLC Abb Vie Inc. Call Options Transaction History

Ingalls & Snyder LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 03, 2021	BUY	$105.21 - $117.21 $10,521 - $11,721	100 Added 0.6%	16,700 $1.88 Million
Q1 2021 Apr 21, 2021	BUY	$102.3 - $112.62 $685,410 - $754,554	6,700 Added 67.68%	16,600 $1.8 Million
Q4 2020 Jan 27, 2021	BUY	$80.49 - $108.67 $531,234 - $717,222	6,600 Added 200.0%	9,900 $1.06 Million
Q3 2020 Oct 21, 2020	BUY	$85.91 - $100.83 $283,503 - $332,739	3,300 New	3,300 $289,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

Stay updated on Ingalls & Snyder LLC with notifications on news.